Skip Nav Destination
Issues
15 December 2021
-
Cover Image
Cover Image
Multiple ESR1 gene fusions have been recently identified in estrogen receptor alpha–positive (ERα+) metastatic breast cancer (depicted by the Circos plot). Active ERα fusion proteins enter the nucleus (depicted by the immunofluorescence) and drive estrogen-independent transcription of estrogen response and epithelial-to-mesenchymal transition genes (depicted by the heatmap), which form a diagnostic 24-gene signature (depicted by the ROC curve). This signature accurately diagnosed the presence of active ESR1 fusions and mutations expressed in ERα+ patient-derived xenografts and metastatic breast cancer patients. For details, see the article by Gou and colleagues on page 6259.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Insights
Review
Cancer Research Landmarks
Cancer Research Highlights
Controversy and Consensus
Genome and Epigenome
Activation of Notch and Myc Signaling via B-cell–Restricted Depletion of Dnmt3a Generates a Consistent Murine Model of Chronic Lymphocytic Leukemia
Anat Biran; Shanye Yin; Helene Kretzmer; Elisa ten Hacken; Salma Parvin; Fabienne Lucas; Mohamed Uduman; Catherine Gutierrez; Nathan Dangle; Leah Billington; Fara Faye Regis; Laura Z. Rassenti; Arman Mohammad; Gabriela Brunsting Hoffmann; Kristen Stevenson; Mei Zheng; Elizabeth Witten; Stacey M. Fernandes; Eugen Tausch; Clare Sun; Stephan Stilgenbauer; Jennifer R. Brown; Thomas J. Kipps; John C. Aster; Andreas Gnirke; Donna S. Neuberg; Anthony Letai; Lili Wang; Ruben D. Carrasco; Alexander Meissner; Catherine J. Wu
Molecular Cell Biology
Tumor Biology and Immunology
A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair
Emilia M. Pulver; Chirantani Mukherjee; Gerarda van de Kamp; Stefan J. Roobol; Magdalena B. Rother; Hanneke van der Gulden; Roebi de Bruijn; Maria Valeria Lattanzio; Eline van der Burg; Anne Paulien Drenth; Nicole S. Verkaik; Kerstin Hahn; Sjoerd Klarenbeek; Renske de Korte-Grimmerink; Marieke van de Ven; Colin E.J. Pritchard; Ivo J. Huijbers; Bing Xia; Dik C. van Gent; Jeroen Essers; Haico van Attikum; Arnab Ray Chaudhuri; Peter Bouwman; Jos Jonkers
Heterogeneity of Circulating Tumor Cell–Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response
Nisha Kanwar; Zaldy Balde; Ranju Nair; Melanie Dawe; Shiyi Chen; Manjula Maganti; Eshetu G. Atenafu; Sabrina Manolescu; Carrie Wei; Amanda Mao; Fred Fu; Dan Wang; Alison Cheung; Yulia Yerofeyeva; Rachel Peters; Kela Liu; Christine Desmedt; Christos Sotiriou; Borbala Szekely; Janina Kulka; Trevor D. McKee; Naoto Hirano; John M.S. Bartlett; Martin J. Yaffe; Philippe L. Bedard; David McCready; Susan J. Done
Translational Science
HER3 Is an Actionable Target in Advanced Prostate Cancer
Veronica Gil; Susana Miranda; Ruth Riisnaes; Bora Gurel; Mariantonietta D'Ambrosio; Alessandro Vasciaveo; Mateus Crespo; Ana Ferreira; Daniela Brina; Martina Troiani; Adam Sharp; Beshara Sheehan; Rossitza Christova; George Seed; Ines Figueiredo; Maryou Lambros; David Dolling; Jan Rekowski; Abdullah Alajati; Matthew Clarke; Rita Pereira; Penny Flohr; Gemma Fowler; Gunther Boysen; Semini Sumanasuriya; Diletta Bianchini; Pasquale Rescigno; Caterina Aversa; Nina Tunariu; Christina Guo; Alec Paschalis; Claudia Bertan; Lorenzo Buroni; Jian Ning; Suzanne Carreira; Paul Workman; Amanda Swain; Andrea Califano; Michael M. Shen; Andrea Alimonti; Antje Neeb; Jonathan Welti; Wei Yuan; Johann de Bono; PCF/SU2C International Prostate Cancer Dream Team
A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment
Feng Xu; Man Tong; Cindy S.W. Tong; Becky K.C. Chan; Hoi Yee Chu; Tin Lok Wong; John H.C. Fong; Maggie S.H. Cheung; Kylie Hin-Man Mak; Lakhansing Pardeshi; Yuanhua Huang; Koon Ho Wong; Gigi C.G. Choi; Stephanie Ma; Alan S.L. Wong
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Xuxu Gou; Meenakshi Anurag; Jonathan T. Lei; Beom-Jun Kim; Purba Singh; Sinem Seker; Diana Fandino; Airi Han; Saif Rehman; Jianhong Hu; Viktoriya Korchina; Harshavardhan Doddapaneni; Lacey E. Dobrolecki; Nicholas Mitsiades; Michael T. Lewis; Alana L. Welm; Shunqiang Li; Adrian V. Lee; Dan R. Robinson; Charles E. Foulds; Matthew J. Ellis
Population and Prevention Science
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer
Jane C. Figueiredo; Noah M. Merin; Omid Hamid; So Yung Choi; Tucker Lemos; Wendy Cozen; Nathalie Nguyen; Laurel J. Finster; Joslyn Foley; Justin Darrah; Jun Gong; Ronald Paquette; Alain C. Mita; Robert Vescio; Inderjit Mehmi; Reva Basho; Warren G. Tourtellotte; Carissa A. Huynh; Gil Y. Melmed; Jonathan Braun; Dermot P.B. McGovern; Emebet Mengesha; Greg Botwin; John C. Prostko; Edwin C. Frias; James L. Stewart; Sandy Joung; Jennifer Van Eyk; Joseph E. Ebinger; Susan Cheng; Kimia Sobhani; Karen L. Reckamp; Akil Merchant
Advertisement